Markers of Angiogenesis in Ovarian Cancer

Por Merritt, William M., Sood, Anil K.
Publicado em 2007

The Dicey Role of Dicer: Implications for RNAi Therapy

Por Merritt, William M., Bar-Eli, Menashe, Sood, Anil K.
Publicado em 2010

Paclitaxel/carboplatin with or without sorafenib in the first-line treatment of patients with stage III/IV epithelial ovarian cancer: a randomized phase II study of the Sarah Canno...

Por Hainsworth, John D, Thompson, Dana S, Bismayer, John A, Gian, Victor G, Merritt, William M, Whorf, Robert C, Finney, Lindsey H, Dudley, B Stephens
Publicado no Cancer Med (2015)

EphA2 Overexpression is Associated with Lack of Hormone Receptor Expression and Poor Outcome in Endometrial Cancer

Por Kamat, Aparna A., Coffey, Donna, Merritt, William M., Nugent, Elizabeth, Urbauer, Diana, Lin, Yvonne G., Edwards, Creighton, Broaddus, Russell, Coleman, Robert L., Sood, Anil K.
Publicado em 2009

Tumor-Selective Response to Antibody-Mediated Targeting of α(v)β(3) Integrin in Ovarian Cancer

Por Landen, Charles N, Kim, Tae-Jin, Lin, Yvonne G, Merritt, William M, Kamat, Aparna A, Han, Liz Y, Spannuth, Whitney A, Nick, Alpa M, Jennnings, Nicholas B, Kinch, Michael S, Tice, David, Sood, Anil K
Publicado em 2008

Dual metronomic chemotherapy with nab-paclitaxel and topotecan has potent anti-angiogenic activity in ovarian cancer

Por Previs, Rebecca A., Armaiz-Pena, Guillermo N., Lin, Yvonne G., Davis, Ashley N., Pradeep, Sunila, Dalton, Heather J., Hansen, Jean M., Merritt, William M., Nick, Alpa M., Langley, Robert R., Coleman, Robert L., Sood, Anil K.
Publicado no Mol Cancer Ther (2015)

Combined anti-angiogenic therapy against VEGF and integrin alpha(V)beta(3) in an orthotopic model of ovarian cancer

Por Kim, Tae Jin, Landen, Charles N., Lin, Yvonne G., Mangala, Lingegowda S., Lu, Chunhua, Nick, Alpa M., Stone, Rebecca L., Merritt, William M., Armaiz-Pena, Guillermo, Jennings, Nicholas B., Coleman, Robert L., Tice, David A., Sood, Anil K.
Publicado em 2009

Impact of Vessel Maturation on Anti-Angiogenic Therapy in Ovarian Cancer

Por Lu, Chunhua, Thaker, Premal H., Lin, Yvonne G., Spannuth, Whitney, Landen, Charles N., Merritt, William M., Jennings, Nicholas B., Langley, Robert R., Gershenson, David M., Yancopoulos, George D., Ellis, Lee M., Jaffe, Robert B., Coleman, Robert L., Sood, Anil K.
Publicado em 2008

Clinical and Biological Significance of Tissue Transglutaminase in Ovarian Carcinoma

Por Hwang, Jee Young, Mangala, Lingegowda S., Fok, Jansina Y., Lin, Yvonne G., Merritt, William M., Spannuth, Whitney A., Nick, Alpa M., Fiterman, Derek J., Vivas-Mejia, Pablo E., Deavers, Michael T., Coleman, Robert L., Lopez-Berestein, Gabriel, Mehta, Kapil, Sood, Anil K.
Publicado em 2008

HLA Class I Antigen Processing Machinery Component Expression and Intratumoral T-Cell Infiltrate as Independent Prognostic Markers in Ovarian Carcinoma

Por Han, Liz Y., Fletcher, Mavis S., Urbauer, Diana L., Mueller, Peter, Landen, Charles N., Kamat, Aparna A., Lin, Yvonne G., Merritt, William M., Spannuth, Whitney A., Deavers, Michael T., De Geest, Koen, Gershenson, David M., Lutgendorf, Susan K., Ferrone, Soldano, Sood, Anil K.
Publicado em 2008

Focal Adhesion Kinase Targeting Using In vivo Short Interfering RNA Delivery in Neutral Liposomes for Ovarian Carcinoma Therapy

Por Halder, Jyotsnabaran, Kamat, Aparna A., Landen, Charles N., Han, Liz Y., Lutgendorf, Susan K., Lin, Yvonne G., Merritt, William M., Jennings, Nicholas B., Chavez-Reyes, Arturo, Coleman, Robert L., Gershenson, David M., Schmandt, Rosemarie, Cole, Steven W., Lopez-Berestein, Gabriel, Sood, Anil K.
Publicado em 2006

Functional Significance of VEGFR-2 on Ovarian Cancer Cells

Por Spannuth, Whitney A., Nick, Alpa M., Jennings, Nicholas B., Armaiz-Pena, Guillermo N., Mangala, Lingegowda S., Danes, Christopher G., Lin, Yvonne G., Merritt, William M., Thaker, Premal H., Kamat, Aparna A., Han, Liz Y., Tonra, James R., Coleman, Robert L., Ellis, Lee M., Sood, Anil K.
Publicado em 2009

Effect of Interleukin-8 Gene Silencing With Liposome-Encapsulated Small Interfering RNA on Ovarian Cancer Cell Growth

Por Merritt, William M., Lin, Yvonne G., Spannuth, Whitney A., Fletcher, Mavis S., Kamat, Aparna A., Han, Liz Y., Landen, Charles N., Jennings, Nicholas, De Geest, Koen, Langley, Robert R., Villares, Gabriel, Sanguino, Angela, Lutgendorf, Susan K., Lopez-Berestein, Gabriel, Bar-Eli, Menashe M., Sood, Anil K.
Publicado em 2008

Bridging the gap between cytotoxic and biologic therapy with metronomic topotecan and pazopanib in ovarian cancer

Por Merritt, William M., Nick, Alpa M., Carroll, Amy R., Lu, Chunhua, Matsuo, Koji, Dumble, Melissa, Jennings, Nicholas, Zhang, ShuYun, Lin, Yvonne G., Spannuth, Whitney A., Kamat, Aparna A., Stone, Rebecca L., Shahzad, Mian M.K., Coleman, Robert L., Kumar, Rakesh, Sood, Anil K.
Publicado em 2010

Anti-angiogenic properties of metronomic topotecan in ovarian carcinoma

Por Merritt, William M., Danes, Christopher G., Shahzad, Mian M.K., Lin, Yvonne G., Kamat, Aparna A., Han, Liz Y., Spannuth, Whitney A., Nick, Alpa M., Mangala, Lingegowda S., Stone, Rebecca L., Kim, Hye Sun, Gershenson, David M., Jaffe, Robert B., Coleman, Robert L., Chandra, Joya, Sood, Anil K.
Publicado em 2009

Clinical and biological impact of EphA2 overexpression and angiogenesis in endometrial cancer

Por Merritt, William M, Kamat, Aparna A, Hwang, Jee-Young, Bottsford-Miller, Justin, Lu, Chunhua, Lin, Yvonne G, Coffey, Donna, Spannuth, Whitney, Nugent, Elizabeth, Han, Liz Y, Landen, Charles N, Nick, Alpa M, Stone, Rebecca L, Coffman, Karen T, Bruckheimer, Elizabeth, Broaddus, Russell, Gershenson, David M, Coleman, Robert L, Sood, Anil K
Publicado em 2010

Antiangiogenic and Antitumor Effects of Src Inhibition in Ovarian Carcinoma

Por Han, Liz Y., Landen, Charles N., Trevino, Jose G., Halder, Jyotsnabaran, Lin, Yvonne G., Kamat, Aparna A., Kim, Tae-Jin, Merritt, William M., Coleman, Robert L., Gershenson, David M., Shakespeare, William C., Wang, Yihan, Sundaramoorth, Raji, Metcalf, Chester A., Dalgarno, David C., Sawyer, Tomi K., Gallick, Gary E., Sood, Anil K.
Publicado em 2006

A novel platform for detection of CK+ and CK− CTCs

Por Pecot, Chad V., Bischoff, Farideh Z., Mayer, Julie Ann, Wong, Karina L., Pham, Tam, Bottsford-Miller, Justin, Stone, Rebecca L., Lin, Yvonne G., Jaladurgam, Padmavathi, Roh, Ju Won, Goodman, Blake W., Merritt, William M., Pircher, Tony J., Mikolajczyk, Stephen D., Nick, Alpa M., Celestino, Joseph, Eng, Cathy, Ellis, Lee M., Deavers, Michael T., Sood, Anil K.
Publicado em 2011

Converging Evidence for Efficacy from Parallel EphB4 Targeted Approaches in Ovarian Carcinoma

Por Spannuth, Whitney A., Mangala, Lingegowda S., Stone, Rebecca L., Carroll, Amy R., Nishimura, Masato, Shahzad, Mian M.K., Lee, Sun-Joo, Moreno-Smith, Myrthala, Nick, Alpa M., Liu, Ren, Jennings, Nicholas B., Lin, Yvonne G., Merritt, William M., Coleman, Robert L., Vivas-Mejia, Pablo E., Zhou, Yue, Krasnoperov, V., Lopez-Berestein, Gabriel, Gill, Parkash S., Sood, Anil K.
Publicado em 2010

Dicer, Drosha, and Outcomes in Patients with Ovarian Cancer

Por Merritt, William M., Lin, Yvonne G., Han, Liz Y., Kamat, Aparna A., Spannuth, Whitney A., Schmandt, Rosemarie, Urbauer, Diana, Pennacchio, Len A., Cheng, Jan-Fang, Nick, Alpa M., Deavers, Michael T., Mourad-Zeidan, Alexandra, Wang, Hua, Mueller, Peter, Lenburg, Marc E., Gray, Joe W., Mok, Samuel, Birrer, Michael J., Lopez-Berestein, Gabriel, Coleman, Robert L., Bar-Eli, Menashe, Sood, Anil K.
Publicado em 2008